Latest Regulatory News

Macro Metals Limited accelerates its transformation into a diversified mining services company through a $4 million strategic placement, a majority Indigenous-owned joint venture, and key asset acquisitions in Western Australia.

Lykos Metals Limited reports significant high-grade mineral findings at its Sinjakovo Project and extends its Jezero exploration permit, alongside key board appointments and cost restructuring.

Felix Gold Limited is advancing plans for near-term antimony production at its historic Scrafford Mine in Alaska, backed by a recent $4.8 million capital raise and strategic positioning amid critical mineral shortages in the U.S.

RooLife Group Ltd (ASX:RLG) reports a remarkable 144% jump in Q2 FY25 sales revenue, driven by new online stores and strategic market entries into China and India. The company’s own branded health and wellness products are central to its growth strategy.

BOA Resources Limited reveals its strategic drilling plans for 2025 targeting key lithium and nickel tenements in Western Australia, alongside a refreshed board and ongoing asset optimisation.

Emyria Limited reports strong progress in its MDMA and psilocybin-assisted therapy programs alongside a successful $2.525 million capital raise, positioning the company for expanded mental health treatment services.

Pilot Energy Limited has announced a substantial 58% increase in the carbon storage capacity of its Cliff Head project, alongside securing $6.3 million in capital and advancing a joint venture for Direct Air Capture technology.

Ark Mines has delivered a significant upgrade to its Sandy Mitchell Rare Earths Project, including a new Mineral Resource Estimate and a completed Scoping Study confirming commercial viability. The company is now preparing for a Pre-Feasibility Study to expand resources and refine project economics.

A1 Investments & Resources Ltd reported a $36,000 net cash outflow for the September quarter, maintaining a slim cash balance of $2,000. The company is actively pursuing acquisitions and plans to raise $300,000 through convertible notes, pending shareholder approval.

Clarity Pharmaceuticals reports robust progress in its SECURE trial and secures FDA Fast Track Designation for its diagnostic agent 64Cu-SAR-bisPSMA, underpinning its growth and innovation in prostate cancer treatment.

Ark Mines Ltd reported a significant cash outflow in its December 2024 quarter, prompting plans for a capital raising to support ongoing exploration activities.

Cokal Limited has strengthened its position in Central Kalimantan through strategic partnerships with PT Petrindo and Cratus Group, securing US$20 million in funding to boost coal production and infrastructure development.